Can Metformin Improve Outcomes When Added to Chemotherapy in Prostate Cancer?
The TAXOMET trial tested the addition of metformin to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Fortamet | Metformin | Prednisone | Prostate Cancer | Taxotere